SAN ANTONIO — The first-in-human trial of ultra-high-dose-rate radiotherapy, known as FLASH therapy, found not only that it was feasible for treating bone metastases, but also that it offered pain ...

PALO ALTO, Calif., August 25, 2025--(BUSINESS WIRE)--Varian, a Siemens Healthineers company, has announced the successful completion of enrollment and treatment in its FAST-02 (Flash Radiotherapy for ...

Command the work room in this professionally tailored blazer in olive plaid.

Flash ultra-high dose rate therapy enabled by Varian proton and planning technologies Collaboration between Varian and leading institutions drives progress toward next-generation cancer treatments ...